The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
Abstract
Objective: To assess whether a potential benefit with combination antibiotic therapy is restricted to the most critically ill subset of patients, particularly those with septic shock. Data Sources: OVID MEDLINE (1950–October 2009), EMBASE (1980–October 2009), the Cochrane Central Register of Controlled Trials (to third quarter 2009), the ClinicalTrial.gov database, and the SCOPUS database. Study Selection: Randomized or observational studies of antimicrobial therapy of serious bacterial infections potentially associated with sepsis or septic shock. Fifty studies met entry criteria. Data Extraction: Study design, mortality/clinical response, and other variables were extracted independently by two reviewers. When possible, study datasets were split into mutually exclusive groups with and without shock or critical illness. Data Synthesis: Although a pooled odds ratio indicated no overall mortality/clinical response benefit with combination therapy (odds ratio, 0.856; 95% confidence interval, 0.71–1.03; p = .0943; I2 = 45.1%), stratification of datasets by monotherapy mortality risk demonstrated substantial benefit in the most severely ill subset (monotherapy risk of death >25%; odds ratio of death, 0.51; 95% confidence interval, 0.41–0.64; I2 = 8.6%). Of those datasets that could be stratified by the presence of shock/critical illness, the more severely ill group consistently demonstrated increased efficacy of a combination therapy strategy (odds ratio, 0.49; 95% confidence interval, 0.35–0.70; p < .0001; I2 = 0%). An increased risk of death was found in low-risk patients (risk of death ≤15% in the monotherapy arm) exposed to combination therapy (odds ratio, 1.53; 95% confidence interval, 1.16–2.03; p = .003; I2 = 8.2%). Meta-regression indicated that efficacy of combination therapy was dependent only on the risk of death in the monotherapy group. Conclusion: Combination antibiotic therapy improves survival and clinical response of high-risk, life-threatening infections, particularly those associated with septic shock but may be detrimental to low-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Self-citationThe epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Advanced methods in meta‐analysis: multivariate approach and meta‐regression
van Houwelingen, H. C., Arends, L. R., & Stijnen, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1040 · Cited by 1,580
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Controlling the risk of spurious findings from meta-regression
Higgins, J. P. T., & Thompson, S. G. (2004) · Statistics in Medicine · doi:10.1002/sim.1752 · Cited by 1,267 · cited 1×
“0001 per 10% increase in aggregate mortality) performed to address the issue of regression to the mean yielded similar results (21, 82, 83).”
ResultEnterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 889
Gogos, C. A., Drosou, E., Bassaris, H. P., & Skoutelis, A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315214 · Cited by 882
(2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2121-4 · Cited by 638
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571
Hilf, M., Yu, V. L., Sharp, J., Zuravleff, J. J., Korvick, J. A., & Muder, R. R. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90695-5 · Cited by 563
Gleason, P. P., Meehan, T. P., Fine, J. M., Galusha, D. H., & Fine, M. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.21.2562 · Cited by 496
Paul, M., Benuri-Silbiger, I., Soares-Weiser, K., & Leibovici, L. (2004) · BMJ · doi:10.1136/bmj.38028.520995.63 · Cited by 466
Baddour, L. M., Yu, V. L., Klugman, K. P., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Luna, C. M., Snydman, D. R., Ko, W. C., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200311-1578oc · Cited by 438
Community-Acquired Bloodstream Infection in Critically Ill Adult Patients
Vallés, J., Rello, J., Ochagavía, A., Garnacho, J., & Alcalá, M. A. (2003) · Chest · doi:10.1378/chest.123.5.1615 · Cited by 431
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Self-citationMartinez, J. A., Horcajada, J. P., Almela, M., Marco, F., Soriano, A., Garcia, E., Marco, M. A., Torres, A., & Mensa, J. (2003) · Clinical Infectious Diseases · doi:10.1086/367541 · Cited by 357
Risk and the Efficacy of Antiinflammatory Agents: Retrospective and Confirmatory Studies of Sepsis
Eichacker, P. Q., Parent, C., Kalil, A., Esposito, C., Cui, X., Banks, S. M., Gerstenberger, E. P., Fitz, Y., Danner, R. L., & Natanson, C. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-302oc · Cited by 341
Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.
Maki, D. G., & Agger, W. A. (1988) · PubMed · Cited by 328
Immunocompromised animal models for the study of antibiotic combinations.
Calandra, T., & Glauser, M. P. (1986) · PubMed · Cited by 287
Leibovici, L., Paul, M., Poznanski, O., Drucker, M., Samra, Z., Konigsberger, H., & Pitlik, S. D. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1127 · Cited by 280
Garnacho-Montero, J., Sa-Borges, M., Sole-Violan, J., Barcenilla, F., Escoresca-Ortega, A., Ochoa, M., Cayuela, A., & Rello, J. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000275389.31974.22 · Cited by 275
META-ANALYSIS IN THE DESIGN AND MONITORING OF CLINICAL TRIALS
DERSIMONIAN, R. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960630)15:12<1237::aid-sim301>3.0.co;2-n · Cited by 257
Enterococcal Bacteremia: Clinical Features, the Risk of Endocarditis, and Management
MAKI, D. G., & AGGER, W. A. (1988) · Medicine · doi:10.1097/00005792-198807000-00005 · Cited by 251
Sensory neuronopathy and small cell lung cancer
Graus, F., Elkon, K. B., Cordon-Cardo, C., & Posner, J. B. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90047-1 · Cited by 246
Schmid, C. H., Lau, J., McIntosh, M. W., & Cappelleri, J. C. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980915)17:17<1923::aid-sim874>3.0.co;2-6 · Cited by 231
Investigating underlying risk as a source of heterogeneity in meta-analysis
Thompson, S. G., Smith, T. C., & Sharp, S. J. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19971215)16:23<2741::aid-sim703>3.0.co;2-0 · Cited by 226
Severity of Pneumococcal Pneumonia Associated With Genomic Bacterial Load
Rello, J., Lisboa, T., Lujan, M., Gallego, M., Kee, C., Kay, I., Lopez, D., & Waterer, G. W. (2009) · Chest · doi:10.1378/chest.09-0258 · Cited by 226
Labro, M.-T. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.615 · Cited by 224
Kumar, A., Haery, C., Paladugu, B., Kumar, A., Symeoneides, S., Taiberg, L., Osman, J., Trenholme, G., Opal, S. M., Goldfarb, R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/498909 · Cited by 221
Self-citationOberholzer, A., Souza, S., Tschoeke, S. K., Oberholzer, C., Abouhamze, A. S., Pribble, J. P., & Moldawer, L. L. (2005) · PubMed · Cited by 219
Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia
Chamot, E., Boffi El Amari, E., Rohner, P., & Van Delden, C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2756-2764.2003 · Cited by 218
Tillotson, J. R., & Finland, M. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.6.597 · Cited by 217
Korvick, J. A., Bryan, C. S., Farber, B., Beam, T. R., Schenfeld, L., Muder, R. R., Weinbaum, D., Lumish, R., Gerding, D. N., & Wagener, M. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2639 · Cited by 212
Rodríguez, A., Mendia, A., Sirvent, J.-M., Barcenilla, F., de la Torre-Prados, M. V., Solé-Violán, J., & Rello, J. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000266755.75844.05 · Cited by 206
Cometta, A., Baumgartner, J. D., Lew, D., Zimmerli, W., Pittet, D., Chopart, P., Schaad, U., Herter, C., Eggimann, P., & Huber, O. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1309 · Cited by 202
Heyland, D. K., Dodek, P., Muscedere, J., Day, A., & Cook, D. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0b013e31816203d6 · Cited by 202
Ko, W.-C., Lee, H.-C., Chuang, Y.-C., Liu, C.-C., & Wu, J.-J. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0654 · Cited by 177
Antimicrobial Synergism in the Therapy of Gram-Negative Rod Bacteremia
Anderson, E. T., Young, L. S., & Hewitt, W. L. (1978) · Chemotherapy · doi:10.1159/000237759 · Cited by 173
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes
Khan, A., Slifer, T., Araujo, F., & Remington, J. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00091-0 · Cited by 167
Vidal, L., Gafter-Gvili, A., Borok, S., Fraser, A., Leibovici, L., & Paul, M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm193 · Cited by 158
Nonantimicrobial Effects of Antibacterial Agents
Pasquale, T. R., & Tan, J. S. (2004) · Clinical Infectious Diseases · doi:10.1086/426545 · Cited by 143
Dupont, H., Carbon, C., & Carlet, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2028-2033.2000 · Cited by 120
Dudas, V., Hopefl, A. W., Jacobs, R. A., & Guglielmo, B. J. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19174 · Cited by 118
Enterococcal Bacteremia: Analysis of 75 Episodes
Gullberg, R. M., Homann, S. R., & Phair, J. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.1.74 · Cited by 114
Kuikka, A., & Valtonen, V. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050164 · Cited by 113
Øvstebø, R., Brandtzaeg, P., Brusletto, B. S., Haug, K. B. F., Lande, K., Høiby, E. A., & Kierulf, P. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.7.2980-2987.2004 · Cited by 111
V�zquez, E., Mensa, J., Mart�nez, J., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1295-9 · Cited by 110
Nosocomial Bacteremia Due to Enterococcus faecalis without Endocarditis
Graninger, W. B., & Ragette, R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/15.1.49 · Cited by 109
Weiss, K., Low, D. E., Cortés, L., Beaupré, A., Gauthier, R., Gregoire, P., Legare, M., Neoveu, F., Thibert, D., & Tremblay, C. L. (2004) · Canadian Respiratory Journal · doi:10.1155/2004/461392 · Cited by 106
ANTIBIOTIC SYNERGY AND ANTAGONISM
Acar, J. F. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70294-7 · Cited by 102
RUOFF, G. E. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90121-x · Cited by 95
Pankuch, G. A., Lin, G., Seifert, H., & Appelbaum, P. C. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00689-07 · Cited by 95
Impact of initial antibiotic choice on mortality from pneumococcal pneumonia
Aspa, J., Rajas, O., de Castro, F. R., Huertas, M. C., Borderías, L., Cabello, F. J., Tábara, J., Hernández-Flix, S., Martinez-Sanchis, A., & Torres, A. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00126004 · Cited by 91
The utility of aminoglycosides in an era of emerging drug resistance
Zembower, T., Noskin, G. A., Postelnick, M. J., Nguyen, C., & Peterson, L. R. (1998) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00033-8 · Cited by 81
Archer, G. L., & Fekety, F. R. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.3.327 · Cited by 72
Effect of Trovafloxacin on Production of Cytokines by Human Monocytes
Khan, A. A., Slifer, T. R., & Remington, J. S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1713 · Cited by 72
Fowler, R., Flavin, K., Barr, J., Weinacker, A. B., Parsonnet, J., & Gould, M. K. (2003) · CHEST Journal · doi:10.1378/chest.123.3.835 · Cited by 70
An Effect Model for the Assessment of Drug Benefit
Boissel, J., Collet, J., Lièvre, M. M., & Girard, P. (1993) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199309000-00003 · Cited by 59
Addition of a macrolide to a ß-lactam in bacteremic pneumococcal pneumonia
Dwyer, R. C., Örtqvist, Å., Aufwerber, E., Normark, B. H., Marrie, T. J., Mufson, M. A., Torres, A., Woodhead, M. A., Ålenius, M., & Kalin, M. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0183-2 · Cited by 59
Korvick, J. A., Peacock, J. E., Muder, R. R., Wheeler, R. R., & Yu, V. L. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.3.620 · Cited by 52
Klebsiella pneumoniae bacteraemia at an urban general hospital
Feldman, C. H., Smith, C. A., Levy, H. A., Ginsburg, P., Miller, S. D., & KOORNHOF, H. J. (1990) · Journal of Infection · doi:10.1016/s0163-4453(90)92258-m · Cited by 50
Kuikka, A., Sivonen, K., Emelianova, A., & Valtonen, V. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01709471 · Cited by 47
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
Gradelski, E., Kolek, B., BONNER, D. P., Valera, L., Minassian, B., & Fung-Tomc, J. C. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00317-4 · Cited by 44
Damas, P., Garweg, C., Monchi, M., Nys, M., Canivet, J.-L., Ledoux, D., & Preiser, J. (2006) · Critical Care · doi:10.1186/cc4879 · Cited by 44
Darras-Joly, C., Bedos, J. P., Sauve, C., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2147 · Cited by 44
Improved Mortality in Gram-negative Bacillary Bacteremia
McCue, J. D. (1985) · Archives of Internal Medicine · doi:10.1001/archinte.1985.00360070082014 · Cited by 43
MONOTHERAPY VERSUS COMBINATION THERAPY FOR BACTERIAL INFECTIONS
Bouza, E., & Muñóz, P. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70293-5 · Cited by 40
Ciprofloxacin Study Group, Krumpe, P. E., Cohn, S. M., Garreltes, J., Ramírez, J. A., Coulter, H., Haverstock, D. C., & ECHOLS, R. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.suppl_1.117 · Cited by 38
Guerrero, M. F., Arnau, C., Valdés, L., Vallvé, C., Gudiol, F., & Rodríguez-Torres, A. (1991) · Infection · doi:10.1007/bf01715772 · Cited by 30
Kljucar, S., Heimesaat, M., von Pritzbuer, E., & Olms, K. (1987) · Infection · doi:10.1007/bf01645868 · Cited by 15
Antman, E. M., Seelig, M. S., Fleischmann, K. E., Lau, J., Kuntz, K. M., Berkey, C. S., & McIntosh, M. W. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf02627951 · Cited by 14
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
“A meta-regression study [167] suggested benefit with combination therapy in patients with a mortality risk greater than 25%.”
BackgroundMethodResultInfluentialSelf-citationKalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citation
Metadata
- Authors
- Kumar, A., Safdar, N., Kethireddy, S., & Chateau, D.
- Venue
- Critical Care Medicine
- Published
- 2010-08
- Volume
- 38
- Issue
- 8
- Pages
- 1651-1664
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2127110195
- Cited by
- 340
- References
- 74
- FWCI
- 14.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.